Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,836 | 109,199 | 109,503 | 93,519 | 107,844 |
| Receivables | 1,014,904 | 899,446 | 722,844 | 641,029 | 529,760 |
| Inventories | 555,643 | 487,349 | 440,703 | 364,319 | 393,441 |
| Other current assets | -1 | 0 | 0 | 0 | 94 |
| TOTAL | $1,673,382 | $1,495,993 | $1,273,050 | $1,098,867 | $1,245,125 |
| Non-Current Assets | |||||
| PPE Net | 178,760 | 172,259 | 169,223 | 147,923 | 149,846 |
| Investments And Advances | 128,654 | 18,498 | 15,732 | 16,509 | 15,704 |
| Intangibles | 6,765,953 | 5,226,098 | 5,536,215 | 5,192,393 | 5,578,657 |
| Other Non-Current Assets | 142,767 | 125,069 | 121,406 | 121,565 | 147,670 |
| TOTAL | $7,216,134 | $5,541,923 | $5,842,575 | $5,478,389 | $5,891,877 |
| Total Assets | $8,889,516 | $7,037,917 | $7,115,625 | $6,577,256 | $7,137,002 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,206,354 | 466,539 | 405,617 | 366,664 | 371,400 |
| Accounts payable and accrued liabilities | 130,733 | 88,389 | 103,190 | 100,272 | 89,302 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 536,760 |
| Other current liabilities | 1,023,875 | 902,914 | 750,582 | 645,250 | 111,344 |
| TOTAL | $2,374,308 | $1,469,403 | $1,270,255 | $1,121,942 | $1,191,960 |
| Non-Current Liabilities | |||||
| Long Term Debt | 837,238 | 922,358 | 882,338 | 914,175 | 1,173,702 |
| Other Non-Current Liabilities | 504,553 | 391,287 | 281,831 | 285,714 | 325,235 |
| TOTAL | $2,097,198 | $1,786,805 | $1,801,832 | $1,793,737 | $2,132,946 |
| Total Liabilities | $4,471,616 | $3,256,208 | $3,072,087 | $2,915,679 | $3,325,095 |
| Shareholders' Equity | |||||
| Common Shares | 21,442 | 20,600 | 20,183 | 18,291 | 18,447 |
| Retained earnings | 2,594,968 | 2,159,174 | 2,425,522 | 2,138,546 | 2,074,010 |
| Other shareholders' equity | -148,236 | -227,752 | -196,236 | -113,216 | 93,654 |
| TOTAL | $4,418,010 | $3,781,813 | $4,043,538 | $3,661,671 | $3,811,907 |
| Total Liabilities And Equity | $8,889,626 | $7,038,021 | $7,115,625 | $6,577,350 | $7,137,002 |